During the past decade, Comprehensive Heart Care, PA conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Comprehensive Heart Care, PA" #1 collaborator was "Medtronic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Comprehensive Heart Care, PA" are "Myocardial Infarction" (2 trials), "Acute Coronary Syndrome" (1 trials), "Coronary Artery Disease" (1 trials), "Heart Failure, Congestive" (1 trials) and "Percutaneous Coronary Intervention" (1 trials). Many other conditions were trialed in "Comprehensive Heart Care, PA" in a lesser frequency.

Most popular intervention types in "Comprehensive Heart Care, PA" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials) and "Plavix (clopidogrel 75 mg) and aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Comprehensive Heart Care, PA" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Comprehensive Heart Care, PA". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Comprehensive Heart Care, PA, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Comprehensive Heart Care, PA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".